Skip to main content

REVIEW article

Front. Pharmacol.
Sec. Pharmacology of Infectious Diseases
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1504154
This article is part of the Research Topic Emerging and Reemerging Neglected Tropical Diseases: Epidemiology, Transmission, Mitigation, and Vaccines and Chemotherapy Advancements View all 8 articles

Clade Ib: A New Emerging Threat in the Mpox Outbreak

Provisionally accepted
SHRIYANSH SRIVASTAVA SHRIYANSH SRIVASTAVA 1Laxmi ... Laxmi ... 1Khyati Sharma Khyati Sharma 1Sathvik Belagodu Sridhar Sathvik Belagodu Sridhar 2Sirajunisa Talath Sirajunisa Talath 3JAVEDH SHAREEF JAVEDH SHAREEF 3Rachana Mehta Rachana Mehta 4*Prakisini Satapathy Prakisini Satapathy 5Ranjit Sah Ranjit Sah 6
  • 1 Delhi Institute of Pharmaceutical Sciences and Research, University of Delhi, New Delhi, India
  • 2 College of Pharmacy, RAK Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates
  • 3 RAK Medical and Health Sciences University, Ras al-Khaimah, Ras al-Khaimah, United Arab Emirates
  • 4 National Public Health Laboratory, Kathmandu, Nepal
  • 5 Center for Global Health Research, Saveetha Medical College & Hospital, Chennai, Tamil Nadu, India
  • 6 Tribhuvan University Teaching Hospital, Kathmandu, Nepal

The final, formatted version of the article will be published soon.

    • Mpox clade Ib accelerates with contact and sexual transmission, putting children, immunocompromised people, and sex workers at risk.• Due to genetic alterations, Mpox transmission has risen, requiring robust infrastructure for early identification and effective antiviral therapy.• AI improves surveillance, diagnosis, and optimization for clade Ib outbreaks; data analysis identifies hotspots for greater precision and effectiveness.• Lessons learned from COVID may reduce healthcare burden and stabilize economies, particularly in low-resource countries.

    Keywords: Clade Ib, Emerging threat, transmission, surveillance, prevention, Outbreaks

    Received: 30 Sep 2024; Accepted: 25 Nov 2024.

    Copyright: © 2024 SRIVASTAVA, ..., Sharma, Sridhar, Talath, SHAREEF, Mehta, Satapathy and Sah. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Rachana Mehta, National Public Health Laboratory, Kathmandu, Nepal

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.